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ABSTRACT: L-Aspartate is a regulatory feedback inhibitor of the biotin-dependent enzyme
pyruvate carboxylase in response to increased levels of tricarboxylic acid cycle intermediates.
Detailed studies of L-aspartate inhibition of pyruvate carboxylase have been mainly conﬁned to
eukaryotic microbial enzymes, and aspects of its mode of action remain unclear. Here we
examine its inhibition of the bacterial enzyme Rhizobium etli pyruvate carboxylase. Kinetic studies
demonstrated that L-aspartate binds to the enzyme cooperatively and inhibits the enzyme
competitively with respect to acetyl-CoA. L-Aspartate also inhibits activation of the enzyme by
MgTNP-ATP. The action of L-aspartate was not conﬁned to inhibition of acetyl-CoA binding,
because the acetyl-CoA-independent activity of the enzyme was also inhibited by increasing
concentrations of L-aspartate. This inhibition of acetyl-CoA-independent activity was
demonstrated to be focused in the biotin carboxylation domain of the enzyme, and it had no
eﬀect on the oxamate-induced oxaloacetate decarboxylation reaction that occurs in the carboxyl
transferase domain. L-Aspartate was shown to competitively inhibit bicarbonate-dependent MgATP cleavage with respect to
MgATP but also probably inhibits carboxybiotin formation and/or translocation of the carboxybiotin to the site of pyruvate
carboxylation. Unlike acetyl-CoA, L-aspartate has no eﬀect on the coupling between MgATP cleavage and oxaloacetate formation.
The results suggest that the three allosteric eﬀector sites (acetyl-CoA, MgTNP-ATP, and L-aspartate) are spatially distinct but
connected by a network of allosteric interactions.
Pyruvate carboxylase (PC, EC 6.4.1.1) is a biotin-dependentcarboxylase, which catalyzes carboxylation of pyruvate to
oxaloacetate. This reaction is considered to be an important
anaplerotic reaction because it replenishes tricarboxylic acid
cycle intermediates that have been withdrawn for anabolic
purposes.1 PC is found in wide variety of organisms, including
eubacteria, yeast, fungi, and animals (for reviews, see refs 1 and
2). In mammals, PC is also involved in gluconeogenesis in liver,
de novo fatty acid synthesis in liver and adipose tissue, and
neurotransmitter synthesis in astrocytes.2,3 Furthermore, PC is
also necessary for glucose-induced insulin secretion in
pancreatic β-cells.4 As PC has such diverse metabolic roles,
dysregulation of this enzyme is involved in many diseases,
including type 2 diabetes, obesity, and cancers.3,5,6
Pyruvate carboxylation catalyzed by PC proceeds through a
series of reactions shown in Figure 1. Reactions 1 and 2, in
which the biotin cofactor is carboxylated via a carboxyphos-
phate intermediate (−O2COPO3
2−), occur in the biotin
carboxylase (BC) domain. Reaction 3, in which the carboxyl
group is transferred from the carboxybiotin to pyruvate to form
oxaloacetate, occurs in the carboxyl transferase (CT) domain.
PC is commonly an α4 tetramer, and the overall pyruvate
carboxylation reaction has been shown to proceed via
intersubunit catalysis where the subunits act in pairs so that
the biotin of one subunit is carboxylated in its own BC domain
but transfers its carboxyl group to pyruvate in its partner
subunit’s CT domain.7
In the majority of organisms, the activity of PC is positively
regulated by the allosteric activator acetyl-CoA as a result of an
increased rate of fatty acid oxidation. This mechanism allows
suﬃcient levels of oxaloacetate to oxidize β-oxidation-derived
acetyl-CoA. In microbes, PC is negatively regulated by L-
aspartate, which signals an abundance of tricarboxylic acid cycle
intermediates. From structural studies of RePC7 and Staph-
ylococcus aureus PC,8 the binding site for acetyl-CoA has been
identiﬁed as an allosteric domain that is surrounded by the BC,
CT, and biotin carboxyl carrier protein (BCCP) domains. The
binding site for L-aspartate has yet to be identiﬁed.
While much has been learned about the action of acetyl-CoA
in a wide variety of organisms (see ref 9 for a review), the
action of L-aspartate has been most extensively studied in the
eukaryotic microbial PCs from Aspergillus nidulans10 and
Saccharomyces cerevisiae.11,12 In both cases, the inhibition was
reported to be competitive with respect to acetyl-CoA; in A.
nidulans, PC L-aspartate decreased the cooperativity of
activation of the enzyme by acetyl-CoA, while in S. cerevisiae
PC, it increased the cooperativity. Much less is known about
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the inhibitory eﬀects of L-aspartate in bacterial PCs, and in
general, the loci and mechanisms of action of L-aspartate are
not well understood. In this study, we have performed a
detailed steady-state kinetic analysis of the inhibitory eﬀects of
L-aspartate on RePC, which has been extremely thoroughly
characterized in structural and mechanistic terms,7,13−15 to
investigate the loci of action and inhibitory mechanisms of L-
aspartate.
■ EXPERIMENTAL PROCEDURES
Materials. Sodium pyruvate, sodium oxaloacetate, ATP,
sodium phosphoenolpyruvate, acetyl-CoA, NADH, malate
dehydrogenase, lactate dehydrogenase, and pyruvate kinase
were purchased from Sigma. 2′,3′-O-(2,4,6-Trinitrophenyl)-
adenosine 5′-triphosphate (TNP-ATP) was obtained from Jena
Bioscience. L-Aspartic acid was purchased from Fluka.
RePC Expression and Puriﬁcation. N-Terminally His-
tagged RePC was expressed in Escherichia coli BL21(DE3) and
puriﬁed as described previously.16 The puriﬁed RePC was
resuspended and stored at −80 °C in storage buﬀer containing
30% (v/v) glycerol, 100 mM Tris-HCl (pH 7.8), and 1 mM
dithioerythreitol.17
Pyruvate Carboxylation Activity Assay. The pyruvate
carboxylating activities in the absence or presence of acetyl-
CoA were determined by a coupled spectrophotometric assay
in which the oxaloacetate produced was converted to malate
with concomitant oxidation of NADH in a reaction catalyzed
by malate dehydrogenase.13 The assays were performed at 30
°C in 1 mL reaction mixtures containing 0.1 M Tris-HCl (pH
7.8), 20 mM NaHCO3, 6 mM MgCl2, 1 mM MgATP, 0.2 mM
NADH, 10 mM sodium pyruvate, and 5 units of malate
dehydrogenase. The concentrations of acetyl-CoA and L-
aspartate were varied from 0 to 150 μM and from 0 to 8
mM, respectively.
To determine the eﬀect of L-aspartate inhibition on the
MgTNP-ATP activation of pyruvate carboxylation, MgTNP-
ATP concentrations were varied from 0 to100 μM at diﬀerent
L-aspartate concentrations (140 μg of enzyme was used per
assay).
The kapp values were calculated by dividing the initial velocity
by the enzymic biotin concentration in each assay.
Oxamate-Induced Oxaloacetate Decarboxylation. The
activity of oxamate-induced oxaloacetate decarboxylation in the
absence of acetyl-CoA was determined by a coupled
spectrophotometric assay in which the pyruvate produced
was converted to lactate with concomitant oxidation of NADH
in a reaction catalyzed by lactate dehydrogenase.18 All assays
were performed at 30 °C in 1 mL of a reaction mixture
containing 0.1 M Tris-HCl (pH 7.8), 0.22 mM NADH, 1 mM
oxamate, and 4 units of lactate dehydrogenase. The
concentrations of oxaloacetate and L-aspartate were varied
between 0 and 250 μM and between 0 and 8 mM, respectively.
The kcat value was calculated from the initial velocity divided by
the enzymic biotin concentration in each assay.
Bicarbonate-Dependent ATP Cleavage Activity Assay.
The activity of bicarbonate-dependent ATP cleavage reactions
in the absence of acetyl-CoA was determined by a coupled
spectrophotometric assay in which the ADP produced was
converted to ATP with concomitant dephosphorylation of
phosphoenolpyruvate to form pyruvate in a reaction catalyzed
by pyruvate kinase. The pyruvate thus formed was converted to
lactate with concomitant oxidation of NADH in a reaction
catalyzed by lactate dehydrogenase.19 The reactions were
performed at 30 °C in 1 mL mixture containing 0.1 M Tris-HCl
(pH 7.8), 20 mM NaHCO3, 5 mM MgCl2, 0.22 mM NADH,
10 mM phosphoenolpyruvate, 5 units of pyruvate kinase, and 4
units of lactate dehydrogenase. Activities were determined by
varying concentrations of MgATP and L-aspartate from 0 to
1000 μM and from 0 to 8 mM, respectively. The assay was
initiated by the addition of the puriﬁed enzyme (493 μg/each
assay).
Coupling between Oxaloacetate Formation and Pi
Release in the Pyruvate Carboxylation Reaction. To
determine the eﬀect of L-aspartate on the coupling between
oxaloacetate formation and Pi release in the pyruvate
carboxylation assay, the initial rates of oxaloacetate formation
and Pi release were determined in the absence and presence (8
mM) of L-aspartate. The rate of Pi release was measured using
the assay of Black and Jones.20 Brieﬂy, 2% (w/v) ammonium
molybdate·4H2O, 14% (w/v) ascorbic acid in 50% (v/v)
trichloroacetic acid, and 2% (w/v) trisodium citrate·2H2O with
2% (w/v) sodium arsenite in 2% (v/v) acetic acid were
prepared as reagents A−C, respectively; 200 μL of reagent A,
300 μL of reagent B, and 800 μL of water were added to the
cuvette followed by the addition of 200 μL samples of the
pyruvate carboxylation reaction mixture 4, 8, 12, and 16 min
after the start of the reaction. The solution was immediately
mixed and stood for 1 min, after which 1 mL of reagent C was
added. The blue color developed within 4 min, and the
absorbance was measured at 700 nm. A standard curve of a
range of Pi concentrations was prepared using a standard
solution of NaH2PO4 in 0.1 M Tris (pH 7.8) and the assay
described above. The Pi content of the pyruvate carboxylation
reaction mixtures was calculated from the standard curve. From
plots of Pi released versus time, the initial rates of Pi release
were calculated by linear regression analysis for triplicate time
courses. The initial rates of oxaloacetate formation were
determined from spectrophotometric assays using the malate
dehydrogenase coupling reaction, as described above. The
reactions were initiated by addition of the puriﬁed RePC (35
μg/assay). The coupling between oxaloacetate formation and Pi
release was calculated as the ratios of initial rates of these two
reactions, and three separate sets of measurements were taken
so that ratios are reported as the mean and standard deviations
of these measurements.
Data Analysis. The acetyl-CoA dependence or MgTNP-
ATP dependence of the pyruvate carboxylation reaction at each
Figure 1. Partial reactions catalyzed by pyruvate carboxylase. Reactions 1 and 2 occur in the BC domain, and reaction 3 occurs in the CT domain.
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concentration of L-aspartate was analyzed by using nonlinear
least-squares regression ﬁts of the data to eq 1.
= + +k k k K K[ ( /[A]) ]/[1 ( /[A]) ]h happ 0 cat a a1 1 (1)
where [A] is either the acetyl-CoA concentration or the
MgTNP-ATP concentration, Ka is the activation constant, h1 is
the Hill coeﬃcient of cooperativity, kapp is the apparent catalytic
rate constant for the reaction at each concentration of L-
aspartate, k0 is the catalytic rate constant of the acetyl-CoA-
independent reaction (determined experimentally), and kcat is
the catalytic rate constant of the acetyl-CoA-dependent reaction
when acetyl-CoA is saturating. A global analysis of the acetyl-
CoA activation of pyruvate carboxylating activities at the
diﬀerent, ﬁxed concentrations of L-aspartate was performed by a
nonlinear least-squares regression ﬁt of the complete set of data
initially to eq 2 that was derived for the reaction scheme in
Figure 2, which describes competitive inhibition by L-aspartate
with respect to acetyl-CoA but where kasp is set to zero.
= + +
+
k k k K K
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where k0, kcat, Ka, and h1 are as described for eq 1 except they
are the values of these parameters in the absence of L-aspartate,
[Asp] is the concentration of L-aspartate, Ki is the dissociation
constant of the enzyme−aspartate complex, and h2 is the Hill
coeﬃcient of cooperativity for the binding of L-aspartate to the
RePC tetramer.
Inactivation of pyruvate carboxylating activity by L-aspartate
in the absence of acetyl-CoA was analyzed by using nonlinear
least-squares regression ﬁts of the data to eq 3.
= + +k k k K K[ ([Asp]/ ) ]/[1 ([Asp]/ ) ]h happ 0 asp i i2 2 (3)
where the parameters are as described for eq 2, except for kasp,
which is the catalytic rate constant for the pyruvate
carboxylation reaction conducted by the enzyme·L-aspartate
complex. The value of k0 was determined experimentally.
The data in Figure 3 were subsequently ﬁt to eq 4, where the
value of kasp was set at the value determined from the analysis of
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The kinetics of oxamate-induced oxaloacetate decarboxyla-
tion in the absence of acetyl-CoA at diﬀerent L-aspartate
concentrations were analyzed by nonlinear least-squares
regression ﬁts of the data to eq 5.
= + +k k K K/(1 /[OAA] [OAA]/ )app cat OAA I (5)
where KOAA and [OAA] are the Michaelis−Menten constant
for and the concentration of oxaloacetate, respectively. KI is the
substrate inhibition constant for oxaloacetate.
The data describing inhibition of the bicarbonate-dependent
MgATP cleavage reaction by L-aspartate were analyzed by a
nonlinear least-squares regression ﬁt initially to eq 6 that
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= + +k k K K/[ (1 [Asp]/ )/[MgATP] 1]app cat m i (7)
where Km is the Michaelis−Menten constant for MgATP, Ki is
the dissociation constant of the enzyme·L-aspartate complex,
and Kis is that for the enzyme·L-aspartate·MgATP complex.
■ RESULTS
Eﬀect of Increasing L-Aspartate Concentrations on
the Activation of Pyruvate Carboxylation by Acetyl-
CoA. Table 1 shows the parameters estimated from the ﬁts of
eq 1 to each individual set of data at each concentration of L-
aspartate shown in Figure 3 and k0. This clearly shows that Ka
increases with increasing L-aspartate concentrations, whereas
there is no strong trend of change in either kcat or h1. However,
k0 does appear to decrease with increasing L-aspartate
concentrations. As mentioned earlier, inhibition of fungal PCs
by L-aspartate has been found to be competitive with respect to
acetyl-CoA. To determine if this could be the case here, we
Figure 2. Reaction scheme showing the proposed inhibitory
mechanism of pyruvate carboxylating activity by L-aspartate in the
presence of acetyl-CoA, where k0 and kcat are catalytic rate constants
for the acetyl-CoA-independent and -dependent reactions catalyzed by
the enzyme (E) and enzyme·acetyl-CoA complex (EAh1), respectively.
The catalytic rate constant for the reaction catalyzed by the enzyme·L-
aspartate complex (EAsph2) is kasp. Ka is the apparent dissociation
constant of the EAh1 complex, and h1 is the Hill coeﬃcient for the
activation process. Ki is the apparent dissociation constant of the
enzyme·L-aspartate complex (EAsph2), and h2 is the Hill coeﬃcient for
the inhibition by L-aspartate.
Figure 3. Eﬀect of increasing concentrations of L-aspartate [(●) 0,
(▲) 2, (▽) 4, (◆) 6, and (○) = 8 mM] on the activation of the
pyruvate carboxylation reaction by acetyl-CoA. The lines represent a
global, nonlinear least-squares regression ﬁt of the data to eq 2.
Reaction conditions were as described in Experimental Procedures.
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developed a model (Figure 2) that describes this type of
inhibition and from which eq 2 was derived. The data in Figure
3 were globally ﬁt to this equation, and the solid lines in Figure
3 represent the ﬁt. As one can see, the ﬁt was good with an R2
of 0.992. The following parameters were estimated from the ﬁt:
kcat = 23.7 ± 0.2 s
−1, Ka = 7.70 ± 0.27 μM, h1 = 2.65 ± 0.09, Ki
= 1.26 ± 0.08 mM, and h2 = 2.78 ± 0.11. The value of h2
suggests that the binding of l-aspartate to RePC is also
cooperative with a Hill coeﬃcient similar to that for acetyl-
CoA. A ﬁt of eq 2 in which h2 was set to 1 (no allosteric binding
of L-aspartate) failed to give a good ﬁt to the data.
Eﬀect of Increasing L-Aspartate Concentrations on
the Pyruvate Carboxylation Reaction in the Absence of
Acetyl-CoA. Figure 4 shows a plot of kapp at diﬀerent
concentrations of L-aspartate in the absence of acetyl-CoA. The
data were ﬁt to eq 3 that describes inhibition that depends on
[L-aspartate]h2, using the value of h2 estimated above. The ﬁt to
eq 3 gave values of Ki and kasp of 2.2 ± 0.2 mM and 0.19 ± 0.01
s−1, respectively. The value of Ki is somewhat higher than that
estimated for the global ﬁt of the data in Figure 3, but the data
set in Figure 4 is much smaller. The positive value of kasp, which
is signiﬁcantly diﬀerent from zero (t test; p < 0.01), indicated
that at a saturating concentration of L-aspartate, the enzyme
retains some residual activity. Reﬁtting the data in Figure 3 to
eq 4, which accounts for this residual activity in the enzyme·L-
aspartate complex, resulted in only very small changes to the
estimated parameters: kcat = 23.7 ± 0.2 s
−1, Ka = 7.70 ± 0.27
μM, h1 = 2.69 ± 0.09, Ki = 1.25 ± 0.07 mM, and h2 = 2.81 ±
0.11.
Eﬀect of Increasing L-Aspartate Concentrations on
the Activation of Pyruvate Carboxylation by MgTNP-
ATP. Figure 5 shows the eﬀects of L-aspartate on the activation
of pyruvate carboxylation by MgTNP-ATP, with each set of
data at individual L-aspartate concentrations ﬁt to eq 1. The
estimated parameters from these ﬁts are listed in Table 2. It is
clear that with increasing concentrations of L-aspartate the value
of Ka increases markedly and, as expected, that of k0 decreases.
The value of kcat also appears to decrease with increasing
concentrations of L-aspartate; however, the value of kcat at 8
mM L-aspartate is not signiﬁcantly diﬀerent from that at 0 mM
L-aspartate (t test; p > 0.1).
Eﬀect of L-Aspartate on the Coupling between
MgATP Cleavage and Pyruvate Carboxylation. The
coupling between MgATP cleavage in the BC domain and
pyruvate carboxylation in the CT domain was examined by
measuring the rates of the formation of oxaloacetate and release
of Pi in the absence and presence (8 mM) of L-aspartate under
identical reaction conditions. The ratios of oxaloacetate
formation to Pi release in the absence and presence of L-
aspartate (8 mM) were 0.96 ± 0.06 and 0.89 ± 0.06,
respectively. The means ± SD of coupling ratios in the absence
and presence of L-aspartate were found to be not signiﬁcantly
diﬀerent using a t test (p > 0.2). This suggests that binding of L-
aspartate to the enzyme has no eﬀect on the coupling between
the reactions in the BC and CT domain reactions.
Table 1. Kinetic Parameters for Acetyl-CoA Activation of the
Pyruvate Carboxylation Reaction Catalyzed by RePC in the










0 7.3 ± 0.9 2.47 ± 0.21 22.9 ± 0.5 0.32
2 14.5 ± 0.5 2.87 ± 0.26 23.9 ± 0.6 0.27
4 23.7 ± 0.7 2.48 ± 0.16 24.9 ± 0.6 0.23
6 35.6 ± 1.1 2.74 ± 0.22 22.4 ± 0.6 0.21
8 60.5 ± 3.0 2.54 ± 0.21 25.3 ± 1.2 0.19
aAssay conditions: 0.1 M Tris-HCl (pH 7.8), 20 mM NaHCO3, 6 mM
MgCl2, 1 mM MgATP, 0.2 mM NADH, 10 mM sodium pyruvate, and
5 units of malate dehydrogenase (MDH). The concentrations of
acetyl-CoA and L-aspartate were varied from 0 to 150 μM and from 0
to 8 mM, respectively. The parameters (±standard errors) were
estimated from a nonlinear regression ﬁt of the data at each L-aspartate
concentration to eq 1 except k0, which was measured directly.
Figure 4. Eﬀect of increasing concentrations of L-aspartate on the
acetyl-CoA-independent pyruvate carboxylation reaction. Data points
at zero acetyl-CoA concentration were replotted from Figure 3. The
line represents a nonlinear least-squares regression ﬁt of the data to eq
3.
Figure 5. Eﬀect of increasing concentrations of L-aspartate [(●) 0,
(▲) 2, (▽) 4, and (○) 8 mM] on the activation of the pyruvate
carboxylation reaction by MgTNP-ATP. The lines represent a
nonlinear least-squares regression ﬁt of each set data at a particular
concentration of L-aspartate to eq 1, where h1 was set to 2.3, the value
determined previously.13 Reaction conditions were as described in
Experimental Procedures.
Table 2. Kinetic Parameters for MgTNP-ATP Activation of
the Pyruvate Carboxylation Reaction Catalyzed by RePC in
the Presence of Diﬀerent Concentrations of L-Aspartatea
[L-aspartate] (mM) Ka for MgTNP-ATP (μM) kcat (s
−1) k0 (s
−1)
0 16.1 ± 2.9 2.1 ± 0.1 0.48
2 33.5 ± 5.6 1.9 ± 0.1 0.43
4 39.1 ± 6.2 1.6 ± 0.1 0.23
8 85.1 ± 17.6 1.5 ± 0.3 0.16
aAssay conditions: 0.1 M Tris-HCl (pH 7.8), 20 mM NaHCO3, 6 mM
MgCl2, 1 mM MgATP, 0.2 mM NADH, 10 mM sodium pyruvate, and
5 units of malate dehydrogenase (MDH). The concentrations of
MgTNP-ATP and L-aspartate were varied from 0 to 100 μM and from
0 to 8 mM, respectively. The parameters (±standard errors) except k0,
which was measured directly, were estimated from a nonlinear
regression ﬁt of the data at each L-aspartate concentration to eq 1,
where h1 was set to 2.3, the value determined previously.
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Eﬀect of Increasing L-Aspartate Concentrations on
the Partial Reactions of RePC in the Absence of Acetyl-
CoA. To examine how L-aspartate has the observed inhibitory
eﬀect on pyruvate carboxylation in the absence of acetyl-CoA
and to determine the locus of its action, the kinetics of
oxamate-dependent oxaloacetate decarboxylation (CT do-
main)18 and bicarbonate-dependent MgATP cleavage in the
absence of pyruvate (BC domain)19 were measured in the
presence of increasing concentrations of L-aspartate.
Kinetic parameters for oxamate-dependent oxaloacetate
decarboxylation (data not shown) in the absence of L-aspartate
and in the presence of 8 mM L-aspartate were obtained by
ﬁtting the data to eq 5. Comparison of the estimates of these
parameters and their accompanying standard errors using t tests
showed that there were no signiﬁcant diﬀerences among the
values of kcat, KOAA, and KI in the presence of 0 and 8 mM L-
aspartate (p > 0.2 in all cases).
The eﬀects of increasing concentrations of L-aspartate on the
kinetics of bicarbonate-dependent MgATP cleavage in the
absence of pyruvate are shown in Figure 6. The solid lines
represent global ﬁts of the data to eq 7, which describes
competitive inhibition and gave the following estimates for
parameters: kcat = 0.0062 ± 0.0001 s
−1, Km = 11 ± 2 μM, and KI
= 1.2 ± 0.3 mM. A ﬁt to eq 6, which describes mixed inhibition,
gave a ﬁt of the data that was not signiﬁcantly better than the ﬁt
to eq 7 by the variance ratio test (p > 0.1).
■ DISCUSSION
Previously, IC50 values for the inhibition by L-aspartate for PC
have been reported to be in the range of 0.6−4 mM,10,11,21
while Dunn et al.22 reported that 10 mM L-aspartate only
marginally inhibited the enzyme from Sinorhizobium meliloti.
Thus, the Ki value of 1.3 mM obtained for RePC in this study is
at the lower end of the range.
As with PC from S. cerevisiae,11,12 increasing concentrations
of L-aspartate resulted in an increase in the apparent Ka for
activation of the enzyme by acetyl-CoA. However, unlike in the
S. cerevisiae enzyme where increasing L-aspartate concentrations
markedly increased the Hill coeﬃcient of cooperativity for the
activation by acetyl-CoA,11,12 L-aspartate had little eﬀect on the
cooperativity of acetyl-CoA activation in RePC. The com-
petitive nature of the inhibition of RePC by L-aspartate with
respect to acetyl-CoA activation was also noted in the fungal
PCs,10−12 and the antagonistic nature of the inhibition with
respect to acetyl-CoA was noted but not analyzed for PC from
the bacterial enzyme Rhodobacter capsulatus.23 The cooperative
nature of the binding of L-aspartate to RePC has also been
observed in the fungal PCs,10,11 where Hill coeﬃcients of 1.53
and 2.1 have been reported for the enzymes from S. cerevisiae
and A. nidulans, respectively. In a bacterial PC from
Arthrobacter globiformus,24 a Hill coeﬃcient of 2.0 was reported.
Thus, the value of the Hill coeﬃcient of 2.8 reported here for
RePC inhibition by L-aspartate was somewhat higher than these
values, indicating increased cooperativity of binding. In RePC,
the value of the Hill coeﬃcient for L-aspartate inhibition is
similar to that of acetyl-CoA activation, but in the case of PC
from S. cerevisiae,11 the Hill coeﬃcient for L-aspartate inhibition
is greater than that of acetyl-CoA binding; in A. globiformus,24 it
is lower and acetyl-CoA does not activate A. nidulans PC in the
absence of L-aspartate.10
The inhibition of RePC in the absence of acetyl-CoA in this
work has also been reported to occur in the fungal PCs,10,11,13
but there has been little investigation of the mechanism of this
inhibition. We have shown that L-aspartate aﬀects reactions in
the BC domain but not the CT domain of RePC. It is clear that
one mode of action is that of competitive inhibition with
respect to MgATP binding in the bicarbonate-dependent
MgATP cleavage reaction. However, this does not explain the
inhibition of the pyruvate carboxylation reaction of RePC that
was performed in the presence of close to saturating
concentrations of MgATP.13 Because the eﬀect of L-aspartate
does not lie in the CT domain, it is likely that this inhibition of
pyruvate carboxylation occurs in the BC domain. It has been
reported that acetyl-CoA enhances the coupling between the
cleavage of MgATP (as measured by Pi release) and the
formation of carboxybiotin25 and oxaloacetate in RePC.15
However, L-aspartate does not appear to signiﬁcantly aﬀect the
coupling between MgATP cleavage and oxaloacetate formation.
This indicates that the inhibitory eﬀect of L-aspartate at
saturating concentrations of MgATP may be an eﬀect on the
rate of either carboxybiotin formation or the translocation of
carboxybiotin to the CT domain.
As with activation of PCs by acetyl-CoA, there seems to be
considerable variation in the parameters that describe the
inhibition of PCs by L-aspartate, even between bacterial species.
Generally, however, L-aspartate inhibition appears to be
competitive with respect to acetyl-CoA and cooperative. The
question of the mechanism of this competitive inhibition by L-
aspartate then arises. The simplest model would be one in
which L-aspartate and acetyl-CoA compete for the same binding
site on PC. There is, however, some evidence to suggest that
this is not the case. First, Libor et al.21 showed that
modiﬁcation of the thermophilic Bacillus PC with trinitroben-
zenesulfonate speciﬁcally inhibited acetyl-CoA-dependent
enzyme activity but had no eﬀect on the acetyl-CoA-
independent activity or its inhibition by L-aspartate. Moreover,
the presence of acetyl-CoA protected the enzyme against
modiﬁcation. Second, Adina-Zada et al.26 showed that mutation
of key residues in the acetyl-CoA binding site that increased the
Ka between 76- and 252-fold had virtually no eﬀect on the
inhibition of RePC by L-aspartate in the absence of acetyl-CoA.
Thus, it is probable that there is a distinct binding site for L-
aspartate that exerts its eﬀects on acetyl-CoA binding through
allosteric eﬀects. RePC has been crystallized in the presence of
L-aspartate, but because of the high B factors the binding site
for the inhibitor could not be located.27 Adina-Zada et al.13
showed that inhibition of RePC by MgTNP-ATP was also
competitive with respect to acetyl-CoA but that its binding site
was separate from that of the allosteric activator. Like L-
Figure 6. Eﬀect of increasing concentrations of L-aspartate [(●) 0,
(▲) 2, (▽) 4, and (○) 8 mM] on the bicarbonate-dependent MgATP
cleavage reaction in the absence of acetyl-CoA and pyruvate. The lines
represent global ﬁts of the data to eq 7. Reaction conditions were as
described in Experimental Procedures.
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aspartate, MgTNP-ATP was also shown to have allosteric
eﬀects in the absence of acetyl-CoA, but MgTNP-ATP
allosterically activated the enzyme. In this work, we have
shown that L-aspartate also inhibits MgTNP-ATP activation of
RePC. Thus, it is possible that the binding site for L-aspartate is
separate from both that of acetyl-CoA and that of MgTNP-
ATP but that there are allosteric interactions among all three
binding sites.
In summary, we have shown that the inhibition of RePC by
L-aspartate is multifaceted. As with other microbial PCs, the
inhibition is competitive with respect to the allosteric activator,
acetyl-CoA, but there is a component of the inhibition that is
independent of acetyl-CoA. The locus of this part of the
inhibition lies in the BC domain and is comprised in part of
competitive inhibition of MgATP binding and biotin
carboxylation and/or carboxybiotin translocation. Because it
is unlikely that the L-aspartate binding site is in the MgATP
binding site, the acetyl-CoA binding site, or the MgTNP-ATP
binding site, the eﬀects of L-aspartate on acetyl-CoA activation,
MgTNP-ATP activation, and MgATP binding and the eﬀects
on biotin carboxylation and/or carboxybiotin translocation are
allosteric, induced from a remote L-aspartate binding site.
Further understanding of the mechanism of action of L-
aspartate must await a structural resolution of its binding site.
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